Hyperammonemic encephalopathy caused by urinary tract infection with urinary retention.
Sato
Shoichiro
S
Cerebrovascular Division, Department of Medicine, National Cardiovascular Center, Japan. shou-310@d6.dion.ne.jp
Yokota
Chiaki
C
Toyoda
Kazunori
K
Naganuma
Masaki
M
Minematsu
Kazuo
K
D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002439:Cefotaxime / Q000008:administration & dosage; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000175:diagnosis / Q000382:microbiology*; D007275:Injections, Intravenous; D007710:Klebsiella Infections / Q000175:diagnosis*; D007711:Klebsiella pneumoniae; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000382:microbiology*; D011512:Proteus Infections / Q000175:diagnosis*; D011513:Proteus mirabilis; D016896:Treatment Outcome; D001744:Urinary Bladder Calculi / Q000150:complications; D016055:Urinary Retention / Q000382:microbiology; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002439:Cefotaxime